Top Markets
#1 Siren Siren +114.50%
#2 Block Street Block Street +76.27%
#3 DAO Maker DAO Maker +47.17%
#4 MemeCore MemeCore +43.27%
#5 Nockchain Nockchain +26.07%
#6 Layer3 Layer3 +25.76%
#7 Amiko Amiko +25.54%
#8 dKargo dKargo +21.44%
#9 Yooldo Games Yooldo Games +19.47%
#10 Liquid Mercury Liquid Mercury +19.33%
Coin of the day
Siren Siren
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Kedudukan dalam Saham #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Harga Saham
$116.80
Modal Pasaran
$51.47B
Perubahan (1 hari)
0.75%
Perubahan (1 tahun)
-27.59%
Negara
US
Perdagangan Zoetis Inc. (ZTS)

Kategori

Healthcare
Nisbah P/E bagi Zoetis Inc. (ZTS)
Nisbah P/E pada March 2026 TTM: 18.95
Menurut laporan kewangan dan harga saham terkini Zoetis Inc., nisbah P/E semasa (TTM) ialah 18.95. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 38.83.
Sejarah nisbah P/E bagi Zoetis Inc. dari 2009 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 18.95 -36.33%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 17.97 -5.19%
DE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 28.23 48.92%
FR
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 79.35 318.66%
JP
Tikun Olam-Cannbit Pharmaceuticals Ltd Tikun Olam-Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd
TKUN.TA
 -0.65 -103.41%
IL
Haleon plc Haleon plc
Haleon plc
HLN.US
 22.30 17.66%
GB
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.